Abbott Q3 Results Fall Short of Sales Forecast
Abbott (NYSE: ABT) shares declined before hours due to third-quarter results that did not meet the consensus Wall Street forecast.
Shares of ABT fell 2.7% to $129.10 apiece in pre-market trading and continued to dip by more than 3.2% to $128.35 by midday, closing the day slightly up at $129.46 apiece.
The company reported profits of $1.64 billion, equal to 94¢ per share, on sales of $11.37 billion for the three months ended September, with a 6.9% sales increase and a 0.1% year-over-year dip in the bottom line.
Adjusted earnings per share were $1.30, meeting Wall Street expectations, but sales fell short of forecasts, with experts projecting $11.39 billion in revenue.
Medical Device sales grew 15%
Author's summary: Abbott's Q3 results show a 6.9% sales increase.
More News
- Taylor Thomson: The Revenue Leader Who Refuses to Say It's Not in Salesforce, It Doesn't Exist - CEOWORLD magazine
- Diane Keaton cause of death revealed
- 10 Queerly Perfect Halloween Costumes for 2025
- Trade unions demand end to attacks on overseas workforce
- 2025 The Everest Field & Betting Update: Ka Ying Rising Hot Favourite - races.com.au
- Budget battles and bureaucracy plague inland waterways infrastructure
- Republican justices appear poised to destroy what’s left of the Voting Rights Act
- Two decades after beating cancer, Durga Devi’s life becomes a story of hope
- Mon BOE: Summer Sizzler, Avalanche to continue next year after all - Dominion Post